VIASKIN
LIVE

Serial Number

79219735

Owner

DBV TECHNOLOGIES

Filing Date

Aug 17, 2017

Add to watchlist:

No watchlists yet
View on USPTO

VIASKIN Trademark

Serial Number: 79219735 • Registration: 5499984

VIASKIN is a trademark filed by DBV TECHNOLOGIES on August 17, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

DBV TECHNOLOGIES (42 trademarks)

177-181 avenue Pierre Brossolette
Montrouge 92120 , FR

Entity Type: 99

Trademark Details

Filing Date

August 17, 2017

Registration Date

June 26, 2018

Published for Opposition

April 10, 2018

Cancellation Date

January 10, 2025

Goods & Services

Data processing equipment, namely, computers; scientific research apparatus and instruments for laboratories for detecting allergies; downloadable computer software applications for providing information regarding immunotherapy; interfaces for computers; downloadable electronic publications in the nature of informational sheets in the field of immunotherapy

Education services, namely, providing training in the form of classes and seminars in the field of immunotherapy ; organization and conducting of educational colloquiums, educational conferences, and educational conventions in the field of immunotherapy; organization and conducting of non-virtual educational forums in the field of immunotherapy; provision of non-downloadable videos in the field of immunotherapy online; electronic desktop publishing; provision of non-downloadable online electronic publications; organization of exhibitions for educational purposes

Medical instruments, apparatus and devices intended for cutaneous or epicutaneous administration of powdered medicated or cosmetic substances for humans; occlusive dispenser for medical use; medical instrument using the electrostatic properties of a biocompatible medium for the treatment by immunotherapy, all of the aforesaid goods only for human use

Adhesive patches device for administering by cutaneous or epicutaneous means of powdered medical or pharmaceutical substances for human purposes in preventing or treating by immunotherapy; medical patch containing a preparation in powder form for delivering detection agents used for diagnosis; occlusive patch for cutaneous absorption of a powdered medicated substance used in the treatment by immunotherapy, all of the aforesaid goods only for human use

Scientific research services for medical purposes in the field of immunotherapy; research in the field of immunotherapy; scientific research in the field of processing and treatment of allergies; scientific research in the nature of discovery and development of allergens; design of methods for the treatment of allergy-causing by the combination of immune cells from the skin; research and development of new products for others

Medical services in the nature of applying a method for desensitizing by immunotherapy; medical consultancy in the field of desensitization to combat allergies; health counseling services; health care services for treating allergies

Printed publications, namely, magazines in the field of immunotherapy; posters; pamphlets in the field of immunotherapy; printed informational fliers and leaflets featuring information regarding immunotherapy; printed matter in the nature of manual handbooks in the field of immunotherapy; newspapers; booklets in the field of immunotherapy; magazine journals featuring information about immunotherapy; printed instructional or teaching material in the field of immunotherapy excluding apparatus

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Mar 5, 2026 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 18, 2026 INTS
INVALIDATION PROCESSED
Feb 18, 2026 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 10, 2025 INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 10, 2025 INTR
CANCELLED SECTION 71
Jan 10, 2025 C71T
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 13, 2024 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Jun 15, 2024 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 1, 2021 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 19, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 28, 2018 FICS
FINAL DISPOSITION PROCESSED
Sep 28, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 26, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 26, 2018 R.PR
PUBLISHED FOR OPPOSITION
Apr 10, 2018 PUBO
NOTICE OF PUBLICATION
Mar 21, 2018 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 7, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 6, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 6, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 6, 2018 TROA
REFUSAL PROCESSED BY IB
Dec 23, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 5, 2017 RFCS
REFUSAL PROCESSED BY MPU
Dec 5, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 21, 2017 RFCR
NON-FINAL ACTION WRITTEN
Nov 20, 2017 CNRT
ASSIGNED TO EXAMINER
Nov 20, 2017 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 7, 2017 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 3, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 2, 2017 REPR